Tag | Content |
---|
EnhancerAtlas ID | HS007-11020 |
Organism | Homo sapiens |
Tissue/cell | BE2C |
Coordinate | chr3:4547600-4550080 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr3:4548980-4548991 | TTTGACCTTGA | - | 6.14 | Esrra | MA0592.2 | chr3:4548981-4548992 | TTGACCTTGAA | - | 6.14 | RUNX1 | MA0002.2 | chr3:4549953-4549964 | GTCTGTGGTTT | + | 6.62 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_10644 | chr3:4542662-4550173 | CD19_Primary | SE_11257 | chr3:4533655-4563092 | CD20 | SE_13171 | chr3:4549224-4549951 | CD34_Primary_RO01480 | SE_13547 | chr3:4544776-4550219 | CD34_Primary_RO01536 | SE_14254 | chr3:4548954-4549892 | CD34_Primary_RO01549 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I004502 | chr3 | 4544126 | 4550060 |
|
Enhancer Sequence | CTGATCCTCT GCTGATTATA AGCCTAAGAA GTTTAGAAAG AGTAGTTTAT GAGAATAGAA 60 AATAGAACAG ATTAGAAAGT AGAATTATAA CAGCCAATAG GAATGCTTCC TCCGTCCCCC 120 TTTCTCTGTG CTAAGTAAGC ATATTTTCTT TTTCACAATT AATTGTCAAC ATAACTATGA 180 GATAAGCCCT CATTATCCCC ATTCTGCAGA TGAGGAAATT GAGGGCCAGA TAAGGGAGGT 240 AACTTGATTG ACTTCCCATT ACATTTAGAA TAGAAGGCCA ACTTTTTACC CTGGCTTGTG 300 AAGTCCTACT GGCTCTATCT TCTCTACCCT GTCTTTAGCC TGTACTTTCT TCCTTTCCCC 360 ATTAATGCTG CAGACATTGG GCTGGCTTTC TGTTTCTGGA ATTTGCTAAG CTCTTTTCTG 420 CTTTATGGCC TTTGTACTAG CCGTTTACTC TACCTAAAAT GCTCTTCCGC CTGATTTTTT 480 TTTGCATGAC TGCCTCTATC TTGACTTTCA GGTCTTCGCT TAAACATCTC ATCTTGTTTT 540 TTCTGACCAG CCAAAATTGC ATTGTCACTT AATCATATCA CCAGTTTTAA TTTTTTGCAT 600 ATACTCATCA CTATCTGATT TGTCTTGCTT GTTTTATCTG TTTGTTTCCT GTCTGTCTGC 660 CCTCACTAGA ATATAGGTAT CACGGGAGCA GGGACCTTGT ATGTCTTGCT TTGATCTGTA 720 TCCCCAGTAC CTAGTATAGG GGTGGCATAT AGTAGGTATC AATAAATATG TTCGATAAGA 780 AGGAAGATTT AAGTTTCACA TGGAACAGTT CACTTTCTAG AGCCCTGGCT GTTCAGTTTT 840 ATATTTTGCA TTTTCATCCT GTTATATAAA GTTTCCAAAC TTATACAGTG AGAGTCCTAA 900 GCACACAGTC ATTGCCAGGA CAACTCTTAA AGAAAAGTTT ATGGCAGCAG TTTTCAAACT 960 TCTGGCTCTC AGGAGCTCTT TTCATGCCTA AAAACAATTC AGGACCCTAA AGAACTGTTG 1020 ATGTGAGTTA CATCTGTCTG TATTTACAAT GTTAGAAATT AACACTGAGA AAATGAACAC 1080 TGAAAAAATA TTTTTAAAAA CCAATTACAC ATTAACGTAT TGACATATTT TTAATGAACA 1140 ATAAGAATAT TTTCCCAAAC AAAAATTTTG AGAAGAGTAG CAATTTTTTT TTTTTTTTTT 1200 TGCGAATCAC TTTGAGGTCT GGTTTCACAG AACATAGCCG GATTCACAGA TCATATATCT 1260 GTTTCTGTCT TCAGTCTGTT GTTACATCAT GTGCCTTGCA GCCTCTGGAA AACTTCACTG 1320 TACATGTGTG AGAGACTGAG TGAAAATGAA AATAATGCCC CAATGTTATT GTGAAATAGT 1380 TTTGACCTTG AAGTTTCCCT GACCCTTGGG CCACCAGCTC CTAGAGTACA TAGGTAATTT 1440 GAAATGTGGG GTTGTGGCAT GGAACATTAG AGAGAGGGAG AAATTGAAGG CTTAAGTGAC 1500 AGGGTGCAAT TGACCATCTC TAAGTCTGGG TATTGTATGA GATCTTTCTG TTCAGAAAAA 1560 AATGCATGGG GATACTTTTC AGTTGTTTTT GTGAAACAAA ATTGCTTCCT AAAGTTCCTC 1620 CTGAAATGCA AAGAAACGCT GAGAATGTGG AAGCTAGTGG TACTTGTCCT ACGTTCATCT 1680 TTTTCTTATG AGCAAGATTA TACCAAGCAG TCCAGAAGTT CTGCAGTGGG ATGGGTCATT 1740 AAAAAATTAT AAAGCATAGG TTCCTCTCTG TGTCTGAGAA TAGCAGCTTC AAGTGTAACT 1800 TCCTTTATAA CTGTTAGTCT CCAACACTTA CTTTGTTCTT TTTGTAGCTT TTGGCCTCAG 1860 ATGAAGTTGT GTCCTACAAT AGAAATTAGA TTGATGCTTA TTGCTCTTAG GTTCTGTCAT 1920 AACTGGTGTT TAAGGAACCA GGATAGAAGC TTTTAATAAT AGATGAGCTA TATTCTGTGC 1980 TAGCCAGCTT CACTGTTTAA GGAGGTTAAA TGATTACAAA TTCAGGCTTC TGGGGAGTGT 2040 TTTGCGTGTG TCTTGGGTCA GTGATATATA AGATTTTCAC TGTTAAGGTA ATTGTGTGGT 2100 AAAATACAGA GGAGCTTGGT CATCAGGAAA TTAATGGTGC ACTGTGGGGA CGAGGCGAGG 2160 GGTTGCAGGC AGGCAGGGGA TCCAAAGTAC CTGACTCTCA TGCTCAGAAG GGTTTCATTT 2220 AAGGTCAGAC TGTCAGTGGG ACTACCCTGC CACCCGATTA CTGAAAGTCA GACTGTTCAG 2280 CCCCAGTGGC CAGGTGGCTT CATCTTAATT AAACGTAGGA GGCTTGCCTT TGTGTCTTGG 2340 TAAAAACTGG CAGGTCTGTG GTTTTGGGGT CCCTTAACTA GTATAAAGTC AATTTCTCAT 2400 TTCCTCCCAA GCCTGTCCAC CCTTGAAGAT TAAGTGATCC CTTAGGTAAC TTATTGGTTA 2460 ATGAAGTGTT CTACTTTAGT 2480
|